-
Product Name
Obinutuzumab (Synonyms: AFUTUZUMAB; HUMABCD20)
- Documents
-
Description
Anti-CD20 / MS4A1 Antibody (Obinutuzumab)
-
Tested applications
ELISA
-
Species reactivity
Human CD20 / MS4A1
-
Alternative names
AFUTUZUMAB antibody; HUMABCD20 antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-CD20 Antibody (obinutuzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
SEC-HPLC
The purity of Anti-CD20 Antibody (obinutuzumab) is more than 95%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human CD20 VLP at 2 ug/mL can bind Anti-CD20 Antibody (obinutuzumab), EC50=0.01384 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"